Emmaus Life Sciences Inc (EMMA): They will take out those Stop/Loss share...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	86
Posts	6856
Boards Moderated	0
Alias Born	06/28/2007

willlbone

Re: None

Wednesday, 03/30/2022 3:30:40 PM

Wednesday, March 30, 2022 3:30:40 PM

They will take out those Stop/Loss shares at 95 cents.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent EMMA News

Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 09:40:23 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 09:39:29 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 09:38:23 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 09:37:09 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 09:35:30 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 09:34:12 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 09:32:13 PM
Form 3/A - Initial statement of beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 12/20/2023 03:33:33 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 12:44:30 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 12:40:45 AM
Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 08:10:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 01:00:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 07:24:09 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 06:48:34 PM

More EMMA News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover